Ascendis Pharma A/S vs Ishares Msci Spain ETF — how do they compare? Ascendis Pharma A/S trades at $255.5 (market cap $16.67B), while Ishares Msci Spain ETF trades at $63.01. The key difference: Ishares Msci Spain ETF is trading nearer its 52-week high, Ascendis Pharma A/S nearer its low. Which is the better fit depends on your goals.
| ASND | EWP | |
|---|---|---|
Market Cap | $16.67B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $277.18 | $62.66 |
52-Week Low | $189.74 | $47.02 |
Enterprise Value | $17.04B | — |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →EWP is a country-specific ETF that tracks the performance of the Spanish equity market. It provides targeted access to large and mid-sized companies in Spain, with heavy weightings in financials and utilities like Banco Santander and Iberdrola.
Read more on EWP →